Literature DB >> 12202510

Osmosensitive taurine transporter expression and activity in human corneal epithelial cells.

Ryo Shioda1, Peter S Reinach, Tatsuhiro Hisatsune, Yusei Miyamoto.   

Abstract

PURPOSE: To characterize in SV40-immortalized human corneal epithelial cells (tHCEC) osmosensitive taurine transporter gene and protein expression as well as its functional activity. To evaluate whether medium supplementation with taurine improves cell viability during a hypertonic challenge.
METHODS: tHCEC were preincubated for up to 48 hours in hypertonic DMEM medium (i.e., up to 500 mosmol/kg). Taurine uptake was monitored through measurements of intracellular [3H]taurine accumulation. Gene and protein expression was detected by Northern and Western blot analyses, respectively. An amino acid analyzer measured intracellular cold taurine content. The live/dead assay evaluated with confocal microscopy determined cell viability.
RESULTS: Na+-dependent taurine uptake occurred in an isotonic (310 mosmol/kg) medium. The apparent Michaelis-Menten constant, K(t), for taurine was 4.6 micro M, and uptake increased as a function of exposure time and rises in osmolality. Exposure for 12 hours to a 450 mosmol/kg medium increased uptake by 4.1-fold. However, after 48 hours of exposure to this medium, taurine uptake returned to its isotonic level. With time, biphasic changes occurred in taurine transporter gene and protein expression and taurine transport activity as well as elevating intracellular taurine content by 4.5-fold. Taurine medium supplementation for 48 hours improved cell viability.
CONCLUSIONS: tHCEC express Na+-dependent osmosensitive taurine transport activity. The hypertonic-induced biphasic effects on gene and protein expression as well as transport activity suggest feedback regulation of these responses. Rises in intracellular taurine do not appear to be essential for osmoregulation, but instead enhance cell survival perhaps through a membrane stabilizer or an antioxidant effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202510

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions.

Authors:  Kaihong Zeng; Hongxia Xu; Mantian Mi; Ka Chen; Jundong Zhu; Long Yi; Ting Zhang; Qianyong Zhang; Xiaoping Yu
Journal:  Neurochem Res       Date:  2010-06-09       Impact factor: 3.996

Review 2.  Introduction to metabolomics and its applications in ophthalmology.

Authors:  S Z Tan; P Begley; G Mullard; K A Hollywood; P N Bishop
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

3.  Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

Authors:  Colleen S Stein; Paul H Yancey; Inês Martins; Rita D Sigmund; John B Stokes; Beverly L Davidson
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

Review 4.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

5.  Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and müller cells.

Authors:  Amira El-Sherbeny; Hany Naggar; Seiji Miyauchi; M Shamsul Ola; Dennis M Maddox; Pamela Moore Martin; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

6.  Metabolic changes reveal the development of schistosomiasis in mice.

Authors:  Junfang Wu; Wenxin Xu; Zhenping Ming; Huifen Dong; Huiru Tang; Yulan Wang
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

7.  Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine.

Authors:  Neeta Khandekar; Mark D P Willcox; Sharon Shih; Peter Simmons; Joseph Vehige; Qian Garrett
Journal:  Mol Vis       Date:  2013-09-19       Impact factor: 2.367

8.  Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment.

Authors:  Silvia Tampucci; Daniela Monti; Susi Burgalassi; Eleonora Terreni; Erica Zucchetti; Filippo Baldacci; Patrizia Chetoni
Journal:  Pharmaceutics       Date:  2018-08-25       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.